Daclawin 60 Mg Tablets Daclatasivir 60mg

Daclawin 60 mg is an antiviral medication that contains Daclatasvir, a potent inhibitor of the Hepatitis C virus (HCV). It is primarily used in the treatment of chronic HCV infection in adults. Daclatasvir targets the NS5A protein, a key component required for viral replication and assembly. By inhibiting this protein, Daclawin effectively stops the virus from multiplying, helping to reduce and eventually eliminate the virus from the body.

Daclawin 60 mg is usually prescribed in combination with other antiviral medications such as Sofosbuvir (Virso 400 mg), and in some cases, Ribavirin, depending on the HCV genotype and liver condition of the patient. It is taken orally once a day, with or without food, for a duration of 12 to 24 weeks as determined by a healthcare provider.

The medication is well tolerated by most patients, though side effects such as fatigue, headache, nausea, and insomnia may occur. Serious side effects are rare, but medical attention should be sought if any unusual symptoms arise.

Daclawin 60 mg has played a crucial role in modern HCV therapy, offering high cure rates and a safer, all-oral alternative to older treatments like interferon. It continues to be a vital option in the global fight against hepatitis C.